economybharat.com

We Can Cover You
Click here
Facebook Youtube Instagram Linkedin
13
13

Therapeutics

Elicera Therapeutics’ drug candidate ELC-100 receives Orphan Drug Designation in the U.S. for the treatment of pancreatic neuroendocrine tumors

Elicera Therapeutics’ drug candidate ELC-100 receives Orphan Drug Designation in the U.S. for the treatment of pancreatic neuroendocrine tumors

creativebharatgroup@gmail.com January 13, 2025
Gothenburg, January 13, 2025 – Elicera Therapeutics AB (publ), a clinical stage cell and...
Read More Read more about Elicera Therapeutics’ drug candidate ELC-100 receives Orphan Drug Designation in the U.S. for the treatment of pancreatic neuroendocrine tumors
MUVON Therapeutics Clears Phase 2 Interim Milestone and Will Participate in the 2025 J.P. Morgan Healthcare Conference 9d47b0d6cde707e1_400x400ar.jpeg

MUVON Therapeutics Clears Phase 2 Interim Milestone and Will Participate in the 2025 J.P. Morgan Healthcare Conference

creativebharatgroup@gmail.com January 9, 2025
PRESS RELEASE   Zurich, Switzerland, January 9, 2025 – MUVON Therapeutics AG,...
Read More Read more about MUVON Therapeutics Clears Phase 2 Interim Milestone and Will Participate in the 2025 J.P. Morgan Healthcare Conference
Orthogon Therapeutics Closes Oversubscribed $5.2M Financing to Advance First Oral Therapy for BK Polyomavirus OG_NewsReleaseCompanyLogo_92815.jpg

Orthogon Therapeutics Closes Oversubscribed $5.2M Financing to Advance First Oral Therapy for BK Polyomavirus

creativebharatgroup@gmail.com December 11, 2024
Canton, Mass., United States:   Orthogon Therapeutics, a developer of novel antiviral medicines,...
Read More Read more about Orthogon Therapeutics Closes Oversubscribed $5.2M Financing to Advance First Oral Therapy for BK Polyomavirus
Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery OG_NewsReleaseCompanyLogo_92766.jpg

Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery

creativebharatgroup@gmail.com December 6, 2024
Seattle, United States:   Parse Biosciences, a leading provider of accessible and scalable...
Read More Read more about Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery
Akiram Therapeutics to Showcase Key Data on AKIR001 at Targeted Radiopharmaceuticals Summit Europe 2024 9f285c147e3e9b6e_400x400ar.png

Akiram Therapeutics to Showcase Key Data on AKIR001 at Targeted Radiopharmaceuticals Summit Europe 2024

creativebharatgroup@gmail.com November 28, 2024
Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, will present breakthrough...
Read More Read more about Akiram Therapeutics to Showcase Key Data on AKIR001 at Targeted Radiopharmaceuticals Summit Europe 2024